Factors Affecting Chemical Exchange Saturation Transfer Imaging on 1.5 T Clinical MRI Scanners

本文探讨1.5 T磁共振化学交换饱和转移(Chemical Exchange Saturation; Transfer,CEST)成像的影响因素.通过试管模型和临床病例,采用GE Signa HDe 1.5 T磁共振成像(Magnetic; Resonance; Imaging,MRI)扫描仪分别进行不同矩阵、激励次数、翻转角、磁化传递翻转角的CEST成像对比分析,以及不同激励次数、磁化传递翻转角的Z谱分; 析,并从成像组织、成像设备、成像技术等方面对原始图信号、酰胺质子转移(Amide Proton Transfer,; APT)信号及Z谱进行分析研究.实验结果表明1.5 T; MRI扫描仪的CEST图像信噪比相对较低,且磁场稳定性及均匀度影响了CEST成像的效果.在其他参数不变的情况下,降低采集矩阵和增加激励次数与翻转; 角可以增加原始图像信噪比.磁化传递翻转角为105?时,CEST成像效果最好.激励次数为2、磁化传递翻转角为105?时,所得数据符合组织Z谱情况.; 模型Z谱在磁化传递频率为-294 ~ -194; Hz范围可显示30%谷氨酸(Glu)、碘剂(I_(320))、纯水(H_2O)、肌酸(Cr)的信号差异,与H_2O差异最大处在-244 ~; -214 Hz.原始图像信号30%; I_(320)明显高于Glu、H_2O、Cr,Cr略低于Glu,APT图Cr略低于Glu.25例脑肿瘤的APT图呈高信号、12例脑梗塞的APT图; 呈低信号,CEST原始图像均可区分病变区域.有12例因采集时间、患者配合情况、环境及室温等影响导致CEST成像的失败.由此得出1.5; T场强下,CEST技术受到成像组织、设备、技术等因素的影响,需要进行多方面优化.在保证磁场稳定性及均匀度的情况下,优化参数的CEST成像和Z谱成; 像可以区分代谢物及其浓度.Acquisition parameters for chemical exchange saturation transfer (CEST); imaging were optimized on a GE Signa HDe 1.5 T magnetic resonance; imaging (MRI) scanner with phantoms and clinical cases. The effects of; matrix size, number of averages (NEX) and flip angles on the quality of; CEST images were assessed. It was shown that the signal-to-noise ratio; (SNR) of the CEST images acquired on the 1.5 T scanner was relatively; low, and the stability and uniformity of the B0 field affected the; outcome significantly. Reducing matrix size and increasing NEX improved; the SNR of the CEST images. Optimal flip angle for magnetization; transfer was found to be 105?. With a NEX of 2, usable Z spectra could; be obtained. The Z spectra indicated that, with the saturation pulse; frequency centered at -294 ~ -194 Hz, signal differences could be; observed for 30% Glu, I_(320), H_2O, and Cr. Maximal signal differences; were observed when the saturation pulse applied at -244 ~ -214 Hz. Amide; proton transfer (APT) imaging on patients showed that 25 cases of brain; tumor had high CEST signals, 12 cases of cerebral infarction had low; CEST signals. It was therefore possible to differentiate brain tumor; from infarction with CEST imaging. There were also 12 cases which failed; due to long acquisition time, patient movements, and temperature changes; in the scanner room.厦门市科技局科技惠民计划资助项目; 卫生部福建省卫生教育联合攻关计划资助项

三苯氧胺抗胆管癌机制的研究进展

胆管癌(cholangiocarcinoma,CCA)是一种来源于肝内或肝外胆管上皮细胞的恶性肿瘤.早期诊断困难,临床疗效差和5年生存率低等特点使之成为临床重点攻坚肿瘤.因此,需要研究和开发新型有效的化疗药物.三苯氧胺(tamoxifen,TAM)是一种非甾体类抗雌激素药物,临床上主要用于乳腺癌的治疗,对其他肿瘤包括CCA也有抑制活性,但具体机制尚不完全清楚.本文主要阐述TAM抗CCA机制的研究进展

Research of chemical exchange saturation transfer in brain

化学交换饱和转移(chemical exchange saturation transfer,CEST)成像是在磁化传递及化学交换理论基础上发展起来的一种磁共振成像新方法,其扩展了磁共振分子影像新领域,但还处于研究阶段。其以细胞内物质为内源性对比剂,通过水信号间接检测代谢物信息,进行组织的酸碱度成像及其各种代谢物成像。本文主要探讨MRI领域中与水相关的化学交换饱和转移现象,阐述其原理、研究现状及其在不同场强磁共振仪上脑部疾病的应用。Chemical exchange saturation transfer(CEST) imaging is a new method for magnetic resonance imaging theory of exchange in the magnetization transfer and chemical, the expansion of the new field of molecular magnetic resonance imaging,but it's still in the research stage. The intracellular substances as an endogenous contrast agent, through the indirect detection of metabolite water signal information for tissue p H imaging and imaging of various metabolites. This paper mainly discusses the chemical and water exchange in the field of MRI saturation transfer phenomenon,expounds the principle, research status and the application in brain diseases used the different field strength clinical MRI scanner.2014年厦门市科技局科技惠民计划项目(编号:3502Z20144052)~

Application of the three-dimensional visualization and 3D printing technology for the preoperative evaluation of retroperitoneal tumors

目的探讨三维重建及3D打印技术在腹膜后肿瘤术前评估中的应用价值。方法回顾性分析2011年3月至2015年9月厦门大学附属成功医院收治的50例腹膜; 后肿瘤病人的临床资料,应用人体器官三维建模软件将病人的CT二维图像重建成三维可视化图像,使用人体器官模型3D打印设备,用两色热塑性塑料打印实物模; 型,通过观察肿瘤与腹腔器官、腹部大血管之间的关系进行术前评估并制定手术方案。实施手术,术中比较重建结果与实际的区别。结果50例病人均成功完成三维; 重建,其中10例病人完成3D打印,三维重建结果及3D打印模型能够立体、清晰和实物化的显示肿瘤解剖学位置及与周围器官、血管的毗邻关系,与术中实际情; 况大致相符。50例病人均顺利施行手术,术中无死亡。结论三维重建及3D打印技术能够对腹膜后肿瘤术前进行精准评估,对指导手术具有一定的应用价值。Objective To explore the application value of three dimensional; visualization and 3D printing technology in the preoperative evaluation; of retroperitoneal tumors. Methods March 2011 to September 2015,the; clinical data of 50 cases of retroperitoneal tumor patients in Xiamen; University Affiliated successful hospital were retrospectively analyzed.; Xiamen strong science and technology R & D human organ 3D modeling; software will reconstruct 2D CT image visualization into a; three-dimensional visualization image,and then it can print physical; model with the company's XMQB-I human organ model 3D printing equipment; and white thermoplastic. At last,preoperative evaluation and surgical; plan can be made through the relationship between the tumor,organs in; abdominal cavity,and abdominal vascular. During the surgery,make a; comparison between the visualization results with the actual condition.; Results 50 cases of patients were successfully completed the; three-dimensional visualization,including 10 cases of patients; completed. Three-dimensional visualization and 3D printing model can; three-dimensionally,clearly show the adjacent relationship between the; anatomical tumour location and surrounding organs and blood; vessels,broadly in line with the actual surgery. 50 surgeries were; successfully performed,no death during perioperative period. Conclusion; Three dimensional visualization and 3D printing technology can make an; accurate preoperative evaluation of retroperitoneal tumors,which has a; certain application value for guiding surgery.国家自然科学基

结肠癌伴孤立巨大肝转移切除术一例

患者男,72岁,因“反复中上腹胀痛不适1月余“入院;既往有乙肝病史,无高血压、糖尿病、心脏病等病史,无手术史。入院查CT示:左肝巨大占位,约22.1 CMx11.3 CM,与胃小弯粘连(图1);门静脉右支无显示(图2),左结肠壁增厚,考虑结肠癌肝转移可能。肿瘤标记物检查示:CEA 54.52μg/l,CA19-9 120.10 u/Ml,AfP正常,血常规、血液生化分析未见国家自然科学基金资助项目(81272246、81101502、61271336、61327001

河蚬乙酸乙酯提取物的抗氧化活性及其对人胆管癌细胞的抑制作用

作为传统中药的河蚬具有退热、治疗肝病和解酒等功效.以新鲜河蚬(Corbicula fluminea)肉为原料,经甲醇抽提,乙酸乙酯萃取等方法得到河蚬乙酸乙酯提取物.运用DPPH法检测其清除自由基的能力,通过MTT法和倒置显微镜观察其对人胆管癌细胞QBC939生长的影响,并通过流式细胞术分析其对QBC939细胞周期的影响.结果显示:河蚬乙酸乙酯提取物对DPPH自由基具有一定的清除作用,在较低的浓度下有较高的清除效果,IC50值为0.6 mg/mL,且随其浓度的增加而不断增强;河蚬乙酸乙酯提取物对QBC939细胞有显著的抑制作用,处理48 h,IC50值为250μg/mL,细胞形态发生明显变化;处理后的QBC939细胞出现明显的凋亡峰.研究表明:河蚬乙酸乙酯提取物不但具有抗氧化活性,且对体外培养的QBC939细胞具有明显的增殖抑制作用,能够改变QBC939细胞周期分布,并诱导QBC939细胞发生凋亡.说明河蚬乙酸乙酯提取物可能具有天然药物开发的潜力,同时也为胆管癌的防治提供新的思路和方法

河蚬提取物对人肝癌细胞SMMC-7721的抑制作用

以河蚬(Corbicula fluminea)为材料,经过甲醇抽提,乙酸乙酯萃取等方法得到河蚬提取物(CFE).用MTT法检测其对肝癌细胞株的抑制作用,借助光学倒置显微镜以及流式细胞术考察CFE对细胞的形态及细胞周期的影响.实验结果表明:CFE对肝癌细胞SMMC-7721有增殖抑制作用,处理72 h细胞形态发生了明显变化,其IC50值为70μg/mL.FMC的结果显示,经CFE处理后的肝癌SMMC-7721细胞出现明显的凋亡峰.这说明CFE有效抑制了体外培养的肝癌细胞增殖,并且能够改变癌细胞的形态及细胞周期的分布,诱导癌细胞出现凋亡

文蛤抗癌多肽抑制肝癌细胞SMMC-7721差异蛋白质组分析

为了研究文蛤抗癌多肽对肝癌细胞抑制作用的蛋白表达差异,寻找并鉴定差异蛋白质,探讨多肽抑制肝癌细胞的作用机理,本文通过双向电泳、考马斯亮蓝染色、M elan ie 4双向软件分析、质谱技术(MALD I-TOF-MS)和数据库检索分析多肽作用SMMC-7721后的差异蛋白质.利用差异蛋白质组方法分析了抗癌多肽对肝癌细胞SMMC-7721抑制后的蛋白变化,找到差异点并进行了质谱鉴定(MALD I-TOF-MS).结果表明,通过对差异蛋白功能的分析,推测抗癌多肽可能引起了肝癌细胞的凋亡,为进一步的抗癌多肽抑制肝癌细胞作用的研究提供了理论基础

文蛤多肽的体外抗癌活性研究

采用硫酸铵沉淀、有机溶剂分离、Sephadex G-25分子筛层析等实验方法,从文蛤肉中提取了一种低分子量的多肽,命名为Mer2.本文以溴化二苯偶氮盐(MTT)法检测Mer2对体外培养的癌细胞的抑制作用.结果表明Mer2对体外培养的人肝癌细胞株(HepG2)、宫颈癌细胞株(Hela)、胆管癌细胞株(QBC939)、肺癌细胞株(SPC-A-1和LTEP-a-2)的生长均有很强的抑制作用,且抑制效果随着Mer2含量的增高和处理时间的延长而增强,证明Mer2具有广谱的抗癌活性.其中Mer2对人肝癌HepG2细胞株抑制作用最为显著,光学显微镜观察经Mer2细胞培养液处理后的细胞形态发生明显的改变,流式细胞仪实验的结果表明处理后的细胞周期发生明显的改变,并在G0/G1期前出现凋亡峰

Effect of sorafenib and celecoxib combination therapy on proliferation of the human cholangiocarcinoma cell line SK-ChA-1 in vitro

目的研究索拉非尼联合塞来昔布在体外对胆管癌细胞株Sk-CHA-1增殖的影响。方法体外培养人胆管癌细胞株Sk-CHA-1,通过MTT法检测索拉非尼单用或与塞来昔布联用时对胆管癌细胞株增殖的抑制作用,WESTErn blOT分析索拉非尼单用或与塞来昔布联用时对胆管癌细胞株内多聚AdP核糖聚合酶(PArP)蛋白表达的影响。结果索拉非尼抑制胆管癌细胞株Sk-CHA-1的增殖并诱导细胞凋亡。索拉非尼联合塞来昔布协同抑制胆管癌细胞株Sk-CHA-1的增殖。塞来昔布使索拉非尼诱导的胆管癌细胞株Sk-CHA-1的凋亡增加。结论索拉非尼联合塞来昔布能协同抑制胆管癌细胞株Sk-CHA-1的增殖,这与塞来昔布使索拉非尼诱导的细胞凋亡增加有关。Objective To investigate the effect of sorafenib and celecoxib combination therapy on proliferation of human cholangiocarcinoma(CC) cells,using the cultured SK-ChA-1 cell line.Methods Inhibition of SK-ChA-1 cell proliferation by sorafenib alone and in combination with celecoxib was studied in vitro using the MTT assay.The anti-neoplastic mechanisms of sorafenib alone and in combination with celecoxib were assessed by Western blot detection of changes in the caspase cleavage substrate poly ADP-ribose polymerase(PARP).Results SK-ChA-1 cells treated with sorafenib alone showed a dose-dependent growth inhibition and degradation of PARP.Combination treatment with sorafenib and celecoxib synergistically increased the growth inhibition effects and enhanced the degradation of PARP.Conclusion Combination treatment with sorafenib and celecoxib results in a synergistic anti-proliferative effect in the human CC cell line SK-ChA-1;the addition of celecoxib enhances sorafenib-induced apoptosis.国家自然科学基金资助项目(81072014